Viewing Study NCT06596278



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06596278
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-11

Brief Title: Memesto Wearable Repetitive Message and Music Therapy Device Music Therapy Device That Senses and Reduces Agitation in People With AD
Sponsor: None
Organization: None

Study Overview

Official Title: Development of Memesto a Wearable Repetitive Message and Music Therapy Device That Senses and Reduces Agitation in Persons With ADADRD
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AWARD
Brief Summary: This is a 12-week proof-of-concept study to evaluate the efficacy of Memesto in reducing agitation in persons with Alzheimers disease and Alzheimers disease related dementias ADADRD currently living in a residential care facility It is hypothesized that Memesto use will result in a reduction in agitation
Detailed Description: After informed consent is obtained and preliminary eligibility established participants will be trained and issued the Memesto device for use over a 2-week screeningtraining phase Participants successfully completing this phase will proceed into a 10-week open label treatment phase via telephone andor in-person data collection

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None